01.28.25 -- Optimizing Reference Standards For Your Biopharmaceutical

By addressing considerations for a comprehensive reference standard strategy, manufacturers can ensure the integrity of biopharmaceuticals, ultimately paving the way for better patient outcomes.

Examine a platform process that is emerging as a simplified and reliable solution for ADC manufacturing, offering efficient process development, purification techniques, and optimization strategies.

It is essential for biopharma companies to stay up to date on the future of CDMOs. Read about three key trends that are helping shape the CDMO industry.

Leverage advanced elemental impurity testing methods to ensure the safety, compliance, and accuracy of your drug products throughout the manufacturing process.

Achieve your therapeutic and commercial goals by utilizing a tried-and-tested standardized approach combined with the latest technology and reliable analytics.

Explore some of the most relevant engineering activities that are necessary to successfully transfer a product from vial into a pre-filled syringe presentation.

Tech transfers can encounter pitfalls at any stage. Learn about these challenges and how to overcome them for successful process replication across different scales and sites.

Whether you’re trying to achieve speed and cost-effectiveness or higher yields and glycosylation capabilities, discover how the right system can be tailored to meet the needs of each unique biologic.